← Health Catalyst, Inc.
| Annual Trend | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net loss | ($47.0m) | ($62.0m) | ($60.1m) | ($115.0m) | ($153.2m) | ($137.4m) | ($118.1m) | ($69.5m) | ($178.0m) | — | |
| Depreciation and amortization | $5.9m | $7.4m | $9.2m | $18.7m | $37.5m | $48.3m | $42.2m | $41.4m | $50.5m | $48.6m | |
| Amortization of debt discount, issuance costs, and deferred financing costs | $153k | $533k | $1.1m | $8.1m | $11.9m | $1.5m | $1.5m | $3.3m | $3.7m | — | |
| Deferred tax provision | $14k | ($163k) | $40k | ($1.3m) | ($7.1m) | ($4.5m) | $8k | $77k | $81k | — | |
| Stock-based compensation expense | $4.2m | $4.2m | $17.8m | $38.0m | $65.1m | $72.1m | $55.8m | $40.1m | $27.0m | $17.6m | |
| Stock-based compensation capitalized as internal-use software | — | $0 | $0 | $181k | $636k | $976k | $889k | $1.0m | $1.0m | $17.6m | |
| Impairment of long-lived assets | — | — | — | $0 | $1.8m | $5.0m | $4.1m | $2.2m | $6.9m | — | |
| Impairment of goodwill and intangible assets | — | — | — | — | — | — | $0 | $0 | $110.2m | — | |
| Accounts receivable, net | $4.4m | ($3.6m) | $127k | ($16.4m) | $102k | $788k | ($13.7m) | $4.3m | ($1.8m) | $19.5m | |
| Accounts payable, accrued liabilities, and other liabilities | ($6.3m) | $4.6m | ($86k) | $8.2m | $5.2m | ($4.7m) | $4.9m | $5.6m | ($11.5m) | $6.2m | |
| Capitalized internal-use software included in accounts payable and accrued liabilities | — | — | — | $0 | $0 | $448k | $169k | $265k | $189k | — | |
| Purchase of property and equipment included in accounts payable and accrued liabilities | $3k | $84k | $209k | $2.3m | $983k | $213k | $7k | $13k | $76k | ($21.7m) | |
| Purchase of intangible assets included in accounts payable and accrued liabilities | $675k | $0 | $1.6m | $78k | $520k | $488k | $1.3m | $0 | $1.7m | — | |
| Deferred revenue | $2.1m | $10.3m | $77k | $11.5m | $7.6m | ($6.0m) | ($1.5m) | ($7.0m) | $607k | — | |
| Other | $0 | $0 | ($15k) | $116k | ($53k) | ($145k) | $67k | $141k | ($429k) | — | |
| Prepaid expenses and other assets | ($815k) | ($1.3m) | ($1.3m) | ($3.7m) | ($4.4m) | ($478k) | $164k | ($50k) | $1.6m | — | |
| Net cash provided by (used in) operating activities | ($36.8m) |
($40.3m)
-9.41%
|
($32.2m)
+20.13%
|
($26.1m)
+18.75%
|
($23.1m)
+11.57%
|
($35.3m)
-52.53%
|
($33.1m)
+6.21%
|
$14.6m
+144.01%
|
$731k
-94.98%
|
$28.2m
+3762.38%
|
|
| Purchases of property and equipment | ($2.5m) | ($2.3m) | ($2.4m) | ($7.8m) | ($10.4m) | ($2.2m) | ($1.2m) | ($1.6m) | ($968k) | ($21.7m) | |
| Proceeds from the sale of property and equipment | $47k | $29k | $62k | $14k | $22k | $29k | $31k | $13k | $44k | — | |
| Proceeds from the sale and maturity of short-term investments | $72.1m | $37.9m | $50.7m | $219.1m | $186.9m | $315.2m | $336.8m | $242.1m | $163.9m | — | |
| Purchases of short-term investments | ($46.4m) | ($14.0m) | ($256.0m) | ($189.5m) | ($261.4m) | ($309.0m) | ($290.8m) | ($168.3m) | ($65.1m) | — | |
| Common stock issued in connection with business acquisitions | — | $0 | $0 | $72.5m | $43.1m | $3.0m | $0 | $24.9m | $31.6m | — | |
| Net cash provided by (used in) investing activities | $22.4m | $21.4m | ($209.6m) | ($82.6m) | ($139.7m) | ($39.0m) | $20.3m | ($22.9m) | $36.2m | ($16.8m) | |
| Proceeds from issuance of long-term debt, net of issuance costs | — | — | — | — | — | $0 | $0 | $152.3m | $0 | $0 | |
| Repayment of debt | — | — | — | — | — | $0 | $0 | ($959k) | $232.3m | ($2.3m) | |
| Repurchase of common stock | $0 | ($8.7m) | $0 | $0 | $0 | ($8.4m) | ($1.8m) | $0 | ($5.0m) | — | |
| Net cash (used in) provided by financing activities | $24.9m |
$24.3m
-2.11%
|
$231.4m
+850.39%
|
$182.6m
-21.08%
|
$264.1m
+44.62%
|
($2.6m)
-100.99%
|
$2.7m
+204.48%
|
$151.7m
+5458.46%
|
($235.8m)
-255.38%
|
— | |
| Net (decrease) increase in cash and cash equivalents | $10.4m | $5.5m | ($10.4m) | $73.9m | $101.3m | ($76.9m) | ($10.0m) | $143.4m | ($198.8m) | — | |
| Cash and cash equivalents at beginning of period | $23.0m | $28.4m | $18.0m | $92.0m | $193.2m | $116.3m | $106.3m | $249.6m | $50.8m | — | |
| Effect of exchange rate changes on cash and cash equivalents | $0 | $0 | $6k | $26k | ($10k) | ($11k) | $21k | ($34k) | $27k | ($84k) | |
| Additional Supplementary Disclosures | |||||||||||
| Additional Supplementary Disclosures | |||||||||||
| Investment discount and premium accretion | $72k | ($143k) | ($615k) | $1.3m | $1.2m | ($2.2m) | ($9.7m) | ($4.8m) | ($1.6m) | — | |
| Non-cash operating lease expense | $1.6m | ($3.9m) | $2.6m | $4.3m | $3.6m | $3.2m | $3.0m | $2.7m | $2.9m | $28.2m | |
| Provision for expected credit losses | — | $359k | $0 | $863k | $499k | $691k | $1.8m | $1.2m | $1.5m | — | |
| Change in fair value of contingent consideration liabilities | — | $0 | $0 | $14.1m | $20.0m | ($4.7m) | $0 | ($1.6m) | ($7.1m) | — | |
| Operating lease liabilities | ($1.7m) | $3.8m | ($2.3m) | ($3.4m) | ($3.9m) | ($3.5m) | ($3.6m) | ($3.5m) | ($4.0m) | — | |
| Capitalization of internal-use software | — | ($197k) | ($384k) | ($1.4m) | ($6.6m) | ($13.0m) | ($12.0m) | ($14.3m) | ($19.8m) | — | |
| Acquisition of businesses, net of cash acquired | — | $0 | $0 | ($101.7m) | ($46.8m) | ($27.8m) | ($11.4m) | ($80.3m) | ($41.1m) | — | |
| Purchases of intangible assets | ($878k) | ($228k) | ($1.9m) | ($1.2m) | ($1.4m) | ($2.3m) | ($1.1m) | ($508k) | ($805k) | — | |
| Payment of deferred financing costs | — | — | — | — | — | $0 | $0 | ($2.2m) | $0 | — | |
| Proceeds from employee stock purchase plan | $0 | $0 | $3.0m | $4.3m | $4.8m | $3.2m | $3.6m | $2.4m | $1.5m | — | |
| Proceeds from exercise of stock options | $76k | $3.0m | $2.7m | $36.3m | $20.4m | $4.0m | $950k | $169k | $0 | — | |
| Cash paid for interest | $1.0m | $3.9m | $5.6m | $5.0m | $6.4m | $5.8m | $5.8m | $10.1m | $21.9m | — | |
| Operating lease right-of-use assets obtained in exchange for operating lease obligations | $0 | $6.6m | $581k | $24.5m | $0 | $169k | $2.0m | $1.3m | $806k | — |